The forecast for the sold production of oxygen-function amino-compounds in the UK, excluding lysine and glutamic acid, indicates a steady decline from 2024 to 2028. Starting at 30.823 million euros in 2024, it is projected to fall to 24.278 million euros by 2028. With an annual decline of approximately 4% to 5% each year, this consistent trend signifies a compound annual growth rate (CAGR) of around -6.3% over the five-year period from 2024 to 2028. As of 2023, the actual production value was 32.5 million euros.
Future trends to watch for include:
- Potential regulatory changes impacting chemical production.
- Technological advancements that could enhance production efficiency.
- Shifts in global demand that may influence local production levels.
